Biomarkers of lung injury after one-lung ventilation for lung resection

Respirology

Volumn 16, Issue 1, 2011, Pages 138-145

  Bastin, Anthony J ^a   Sato, Hiroe ^a   Davidson, Simon J ^b   Quinlan, Gregory J ^a   Griffiths, Mark J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Acute lung injury; Biomarker; Mechanical ventilation; Pulmonary surgical procedure; Ventilatorinduced lung injury

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; EXHALED BREATH CONDENSATE; INTERLEUKIN 6; KREBS VON DEN LUNGEN 6; SURFACTANT; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENDOTHELIUM INJURY; EXPIRED AIR; FEMALE; HUMAN; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG RESECTION; LUNG VENTILATION; MALE; PH MEASUREMENT; PLASMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VENTILATOR INDUCED LUNG INJURY;

ACUTE LUNG INJURY; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREATH TESTS; DINOPROST; FEMALE; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-6; LEUKOTRIENE B4; LUNG; MALE; MIDDLE AGED; MUCIN-1; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; VENTILATOR-INDUCED LUNG INJURY; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 79952275726     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01870.x     Document Type: Article

References (53)

1. Mead J, Takishima T, Leith D. Stress distribution in lungs: a model of pulmonary elasticity. J. Appl. Physiol. 1970; 28: 596-608.
2. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 2000; 342: 1301-8.
3. Parsons PE, Eisner MD, Thompson BT et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 2005; 33: 1-6. (Pubitemid 40116529)
4. Eisner MD, Parsons P, Matthay MA et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58: 983-8. (Pubitemid 37392811)
5. Calfee CS, Ware LB, Eisner MD et al. Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-9.
6. Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit. Care Med. 2001; 29: 2325-31. (Pubitemid 34038167)
7. Ware LB, Eisner MD, Thompson BT et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am. J. Respir. Crit. Care Med. 2004; 170: 766-72. (Pubitemid 39298992)
8. Sato H, Callister ME, Mumby S et al. KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur. Respir. J. 2004; 23: 142-5. (Pubitemid 38088511)
9. Ishizaka A, Matsuda T, Albertine KH et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol. Physiol. 2004; 286: L1088-94.
10. Ranieri VM, Suter PM, Tortorella C et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 282: 54-61. (Pubitemid 29318933)
11. Stuber F, Wrigge H, Schroeder S et al. Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Med. 2002; 28: 834-41. (Pubitemid 34762216)
12. Fernandez-Perez ER, Keegan MT, Brown DR et al. Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy. Anesthesiology 2006; 105: 14-18. (Pubitemid 44305186)
13. van der Werff YD, van der Houwen HK, Heijmans PJ et al. Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest 1997; 111: 1278-84. (Pubitemid 27200085)
14. Licker M, de Perrot M, Spiliopoulos A et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth. Analg. 2003; 97: 1558-65. (Pubitemid 37475100)
15. Jeon K, Yoon JW, Suh GY et al. Risk factors for post-pneumonectomy acute lung injury/acute respiratory distress syndrome in primary lung cancer patients. Anaesth. Intensive Care 2009; 37: 14-19.
16. Moloney ED, Mumby SE, Gajdocsi R et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am. J. Respir. Crit. Care Med. 2004; 169: 64-9. (Pubitemid 38233890)
17. Michelet P, D'Journo XB, Roch A et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology 2006; 105: 911-19. (Pubitemid 44655501)
18. Schilling T, Kozian A, Huth C et al. The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery. Anesth. Analg. 2005; 101: 957-65. (Pubitemid 41383053)
19. Licker M, Diaper J, Villiger Y et al. Impact of intraoperative lung protective interventions in patients undergoing lung cancer surgery. Crit. Care 2009; 13: R41.
20. Horvath I, Hunt J, Barnes PJ et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 2005; 26: 523-48. (Pubitemid 41264218)
21. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 1999; 8: 135-60. (Pubitemid 29425900)
22. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818-24. (Pubitemid 24082248)
23. Wrigge H, Uhlig U, Baumgarten G et al. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005; 31: 1379-87. (Pubitemid 41437731)
24. Wolthuis EK, Choi G, Dessing MC et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology 2008; 108: 46-54.
25. Zupancich E, Paparella D, Turani F et al. Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J. Thorac. Cardiovasc. Surg. 2005; 130: 378-83. (Pubitemid 41074168)
26. Determann RM, Wolthuis EK, Choi G et al. Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L344-50.
27. Choi G, Wolthuis EK, Bresser P et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology 2006; 105: 689-95. (Pubitemid 44477314)
28. Koner O, Celebi S, Balci H et al. Effects of protective and conventional mechanical ventilation on pulmonary function and systemic cytokine release after cardiopulmonary bypass. Intensive Care Med. 2004; 30: 620-6. (Pubitemid 38530097)
29. Wrigge H, Zinserling J, Stuber F et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology 2000; 93: 1413-17.
30. Wrigge H, Uhlig U, Zinserling J et al. The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery. Anesth. Analg. 2004; 98: 775-81. (Pubitemid 38252675)
31. Kutlu CA, Williams EA, Evans TW et al. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann. Thorac. Surg. 2000; 69: 376-80. (Pubitemid 30125562)
32. Hager DN, Krishnan JA, Hayden DL et al. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am. J. Respir. Crit. Care Med. 2005; 172: 1241-5. (Pubitemid 43076561)
33. Griffiths MJ, McAuley DF. RAGE: a biomarker for acute lung injury. Thorax 2008; 63: 1034-6.
34. Walsh BK, Mackey DJ, Pajewski T et al. Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients. Respir. Care. 2006; 51: 1125-31.
35. Craig SR, Leaver HA, Yap PL et al. Acute phase responses following minimal access and conventional thoracic surgery. Eur. J. Cardiothorac. Surg. 2001; 20: 455-63. (Pubitemid 32743327)
36. Borrill ZL, Starkey RC, Singh SD. Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis. 2007; 2: 71-6. (Pubitemid 46915830)
37. Bayley DL, Abusriwil H, Ahmad A et al. Validation of assays for inflammatory mediators in exhaled breath condensate. Eur. Respir. J. 2008; 31: 943-8.
38. Kostikas K, Papatheodorou G, Ganas K et al. pH in expired breath condensate of patients with inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 1364-70. (Pubitemid 34522938)
39. Ojoo JC, Mulrennan SA, Kastelik JA et al. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005; 60: 22-6. (Pubitemid 40101013)
40. Gessner C, Hammerschmidt S, Kuhn H et al. Exhaled breath condensate acidification in acute lung injury. Respir. Med. 2003; 97: 1188-94. (Pubitemid 37337014)
41. Kullmann T, Barta I, Lazar Z et al. Exhaled breath condensate pH standardised for CO2 partial pressure. Eur. Respir. J. 2007; 29: 496-501. (Pubitemid 46372096)
42. Paget-Brown AO, Ngamtrakulpanit L, Smith A et al. Normative data for pH of exhaled breath condensate. Chest 2006; 129: 426-30. (Pubitemid 43289865)
43. Vaughan J, Ngamtrakulpanit L, Pajewski TN et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur. Respir. J. 2003; 22: 889-94. (Pubitemid 37540637)
44. Uchida T, Shirasawa M, Ware LB et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 2006; 173: 1008-15.
45. Bopp C, Hofer S, Weitz J et al. sRAGE is elevated in septic patients and associated with patients outcome. J. Surg. Res. 2008; 147: 79-83. (Pubitemid 351626081)
46. Ikeda M, Furukawa H, Imamura H et al. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor. Gastric Cancer 2002; 5: 137-41. (Pubitemid 35238892)
47. Boldt J, Huttner I, Suttner S et al. Changes of haemostasis in patients undergoing major abdominal surgery - is there a difference between elderly and younger patients? Br. J. Anaesth. 2001; 87: 435-40. (Pubitemid 32827480)
48. Tsang GM, Allen S, Pagano D et al. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 1998; 13: 385-91. (Pubitemid 28231348)
49. Cepkova M, Brady S, Sapru A et al. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury. Crit. Care 2006; 10: R126.
50. Nathani N, Perkins GD, Tunnicliffe W et al. Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit. Care 2008; 12: R12.
51. Sakuma T, Takahashi K, Ohya N et al. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy. Surg. Today 1999; 29: 121-8. (Pubitemid 29088858)
52. Zhang F, Pao W, Umphress SM et al. Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Res. 2003; 63: 5889-94. (Pubitemid 37187489)
53. Ishikawa N, Hattori N, Yokoyama A et al. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors. Int. J. Cancer 2008; 122: 2612-20. (Pubitemid 351590499)